Dapagliflozin ((2S)-1,2-propanediol, hydrate)

CAS: 960404-48-2

Ref. TM-T4460

Produktinformation

• Name: Dapagliflozin ((2S)-1,2-propanediol, hydrate)
• Synonyme: BMS-512148 (2S)-1,2-propanediol, hydrate, Dapagliflozin propanediol monohydrate, (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-<span class="text-smallcaps">D</span>-glucitol (S)-propane-1,2-diol (1:1) monohydrate, <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol (1:1), monohydrate, <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1), Dapagliflozin (S)-propylene glycol hydrate, Dapagliflozin Propylene Glycolate Hydrate, Edistride, Farxiga, Forxiga
• CAS: 960404-48-2

Beschreibung

Dapagliflozin ((2S)-1,2-propanediol, hydrate) (BMS-512148 (2S)-1,2-propanediol, hydrate) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2). It is in development for the treatment of type 2 diabetes mellitus (T2DM). It inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 502.98
• Formel: C₂₄H₃₅ClO₉
• Reinheit: 99.94%
• Farbe/Form: Solid